Table 3.
Baseline | Day 29 | Day 57 = EOT | Day 70 | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|
||||||
n | Median | n | Median | n | Median | n | Median | ||
FSH | DS-TB: BdqLoadPa200Z | 45 | 5.0 | 43 | 5.7 | 37 | 5.6 | 35 | 5.8 |
DS-TB: Bdq200Pa200Z | 47 | 5.2 | 41 | 6.3 | 40 | 5.8 | 39 | 6.3 | |
DR-TB: Bdq200Pa200MfxZ | 36 | 5.6 | 37 | 6.1 | 38 | 6.4 | 37 | 5.7 | |
DS-TB: HRZE | 46 | 4.9 | 45 | 5.9 | 43 | 5.5 | 43 | 5.3 | |
BMI | DS-TB: BdqLoadPa200Z | 43 | 19.3 | 43 | 19.4 | 37 | 19.6 | 35 | 19.8 |
DS-TB: Bdq200Pa200Z | 45 | 19.2 | 41 | 19.7 | 40 | 20.0 | 39 | 20.2 | |
DR-TB: Bdq200Pa200MfxZ | 36 | 18.0 | 37 | 18.3 | 38 | 18.8 | 37 | 18.4 | |
DS-TB: HRZE | 46 | 17.9 | 45 | 18.7 | 43 | 18.9 | 43 | 19.1 |
* All patients in the Pa-containing arms (DS-TB and DR-TB) received 200 mg of Pa.
FSH = follicle stimulating hormone; BMI = body mass index; EOT = end-of-treatment; DS-TB = drug-susceptible TB; BDQ = bedaquiline; Pa = pretomanid; Z = pyrazinamide; DR-TB = drug-resistant TB; MFX = moxifloxacin; H = isoniazid; R = rifampin; E = ethambutol.